Dr. Rick Patt
Co-founder
Dr. Patt is co-founder and principal in RadMD. He has a broad prior experience
in medical imaging: this includes research and development of contrast agents:
design and manage site and central reviews and trained reviewers for over 300
oncology trials; and has expertise in cardiovascular device, infectious disease,
and pulmonary fibrosis trials. He has performed blinded reads and adjudications
in a variety of trial types. He has held positions as both an academic and private
practice radiologist.
After his fellowship at Georgetown University and the National Institutes of Health
(NIH), he served as Chief of Body MRI, then Director of MRI, at Georgetown University
Medical Center, where he was both an investigator and blinded reader in numerous
pharmaceutical and medical device clinical trials.
He subsequently joined Berlex Labs as Associate Director, followed by Director of
Medical Imaging Clinical Development. where he managed an experienced team in all
phases of clinical development of radiological contrast agents.
Dr. Patt also served as Medical Director for HealthHelp, a radiology management
services organization. He founded Foresight Consulting, working with pharmaceutical
and medical device companies on the utilization of medical imaging into clinical
development programs.
He has numerous publications, has served on an NCI Advisory Panel, is a reviewer
for major radiology journals, and has been an invited lecturer across the US and
Europe on the use of medical imaging in clinical trials.
Click here to view Dr. Patt's full CV and publications.
Dr. Kohkan Shamsi
Co-founder
Dr. Shamsi, MD, PhD, co-founder and principal of RadMD is a radiologist
with 25+ years of clinical development experience for drugs and devices.
Before founding RadMD, he worked as research physician at Schering AG in
Berlin, Germany and as Head of Medical Development and clinical operations
at Berlex and Bayer and was CEO of US operations of ECRON ACUNOVA, a global
clinical CRO. He has conceptualized, coordinated, and executed >100
multi-center, international (Europe, the USA, South America, Asia and
Australia) clinical trials (phase I – phase IV) in the areas of oncology,
cardiology, neurology and MRI and CT contrast agents and radiopharmaceuticals.
He has contributed towards development of guidelines for clinical development
of contrast agents for the FDA and EMA, and the FDA draft imaging guidance for
use of imaging in oncology trials. He has authored a book and chapters and published
more than 90 full publications and abstracts in indexed journals. He is also part of
industry initiative for standardization of imaging in clinical trials.
Click here to view Dr. Shamsi's full CV and publications.
Dr. Robert Lavis
Group Medical Director
Dr Robert Lavis joined Medica as Group Clinical Director in 2020 and became
Group Medical Director in June 2021. He graduated from the University of
Birmingham Medical School in 1996. Training initially as a surgeon in the West
Midlands, obtaining MRCS, he then trained as a radiologist in the Peninsula
training scheme gaining his FRCR and a PGCE in Medical Education. He has specialist
interests in Head and Neck and Urology imaging. He has held Consultant and
Clinical Director posts in both Plymouth Hospitals NHST and Gloucestershire
Hospitals NHSFT.
Lyndsey Elliott
Director Project Management
Lyndsey joined RadMD in 2018 as Senior Imaging Program Manager and
progressed to the role of Director, Project Management in January 2020.
Lyndsey has extensive experience within Imaging Research Operations and Project
Management, and initially trained as a Cardiac Physiologist / Sonographer working
in the NHS UK, gaining a BSc with Honors in Clinical Science, from De Montfort
University, Leicester, UK. Prior to joining RadMD, Lyndsey worked for ICON Medical
Imaging as part of the Clinical Operations Team.
Lyndsey is responsible for day to day oversight of Project Management
Operations, driving execution of service, client relationship management
and satisfaction, quality and efficiencies in process within imaging
operations at RadMD.
David Julyk, PhD
Chief Compliance Officer
David joined RadMD as Chief Compliance Officer in 2020. Prior to joining RadMD,
David worked for 10 years in medical imaging as a quality and compliance consultant,
a Director of Quality Assurance and Director of Software Quality. David has over 20 years'
experience in regulatory compliance and quality assurance and specializes in process
development, improvement, and inspection readiness. David has extensive experience in
data protection, software validation, and quality management system development.
David Larlick
Director of Imaging Data Management
David Larlick is the Director of Imaging Data Management for RadMD,
with responsibilities for image quality review, eCRF build and output creation.
He has a background in technology, pre-clinical and imaging trials over the last 20+ years.
David has experience with systems development, quality review, and report creation.
He holds a BS in Management Information Systems and obtained his Certification of
Study in Clinical Research to compliment his work in the industry. David is a
certified advanced SAS programmer.
Judy Currier
Chief Commercial Officer
Judy has dedicated her career to business development in life sciences. After
many years of high performance with Pfizer in commercial sales, she moved to the
CRO arena. Judy has enjoyed several roles of increasing responsibility and leadership
including VP of Global Business Development at Biomedical Systems, Spaulding Clinical.
Most recently she was instrumental in helping AG Mednet launch a novel eclinical technology
to the industry. Judy brings a wide array of expertise's to RadMD, focused on helping
pharmaceutical and medical device companies devise and execute clinical trials, with
particular emphasis on imaging and radiological services.
